FINWIRES · TerminalLIVE
FINWIRES

$MO

13 stories mentioning MOUpdated 27d ago

Every FINWIRES story that references MO, newest first.

Insider Trading

Altria Group Insider Sold Shares Worth $418,318, According to a Recent SEC Filing

Debra J Kelly-Ennis, Director, on May 26, 2026, sold 5,790 shares in Altria Group (MO) for $418,318. Following the Form 4 filing with the SEC, Kelly-Ennis has control over a total of 73,809 common shares of the company, with 73,809 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/764180/000076418026000081/xslF345X05/wk-form4_1779993082.xmlPrice: $72.01, Change: $-0.10, Percent Change: -0.14%

$MO
Equities

S&P 500 Ekes Out Seventh Consecutive Weekly Gain as Energy Leads

The Standard & Poor's 500 index edged up 0.1% this week, its seventh consecutive weekly gain, as a strong advance in energy stocks helped outweigh declines in other sectors.The S&P 500 ended the week at 7,408.50, up slightly on the week but down from the new closing high it reached Thursday at 7,501.24. The market benchmark also hit a new intraday high on Thursday at 7,517.12.The seven-week win streak is the index's longest since a nine-week run that ended in December 2023. The S&P 500 is now up 2.8% for the month and has climbed 8.2% in 2026.The week's advance was driven by gains in only four of the S&P 500's 11 sectors, led by energy amid surging oil prices on the back of renewed Middle East worries. Consumer staples, technology and health care also rose this week.Declines across the remaining seven sectors came amid inflation concerns.US annual consumer inflation accelerated in April to the fastest pace in almost three years as energy prices surged amid the near-complete closure of the Strait of Hormuz, data released this week showed. Another report showed US producer prices in April rose at the fastest pace in four years as broad-based increases in services and goods signaled intensifying inflation pressures.The energy sector jumped 6.8%, followed by gains of at least 1% each in consumer staples, technology and health care.Occidental Petroleum (OXY) and Targa Resources (TRGP) had the largest percentage gains in the energy sector for the week, rising 12% and 9.6%, respectively.The climb in consumer staples was led by shares of tobacco companies Philip Morris International (PM) and Altria Group (MO), which added 11% and 7.3%, respectively.The technology sector's gain came amid enthusiasm for artificial intelligence as Cisco Systems (CSCO) reported higher-than-expected quarterly results, boosted by strong demand for its AI infrastructure. Cisco's shares jumped 22% as the company reported fiscal Q3 earnings and sales above market expectations and raised its full-year guidance.On the downside, consumer discretionary fell 3.1%, followed by a 2.6% drop in real estate, a 2.3% loss in materials, and a 2.1% decline in utilities. Industrials fell 1.1% while communication services and financials also edged lower.Norwegian Cruise Line Holdings (NCLH) was among the hardest-hit stocks in consumer discretionary. The cruise operator's shares fell 9.1% as TD Cowen cut its price target on the stock to $22 each from $27. The firm kept its investment rating on the shares at buy.Next week, a number of retailers will report quarterly earnings, including Walmart (WMT), Target (TGT), Home Depot (HD), Lowe's (LOW), TJX (TJX), and BJ's Wholesale Club (BJ). Other companies on the week's earnings calendar include NVIDIA (NVDA), Analog Devices (ADI), Intuit (INTU) and Deere (DE).Economic data will include April pending home sales, housing starts and building permits, as well as a final reading on May consumer sentiment.

Dow JonesNasdaq CompositeS&P 500$CSCO$MO$NCLH$OXY$PM$TRGP
Wire

Altria Maintains Quarterly Dividend at $1.06 per Share, Payable July 10 to Holders of Record June 15

Altria Maintains Quarterly Dividend at $1.06 per Share, Payable July 10 to Holders of Record June 15

$MO
Wire

Update: Market Chatter: Trump Plans to Fire FDA Commissioner Makary

(Updates with White House comment in last paragraph.)President Donald Trump has approved a plan to fire Food and Drug Administration Commissioner Marty Makary, the Wall Street Journal reported Friday, citing people familiar with the matter.Trump expressed displeasure in recent days with Makary for taking too long to approve flavored vapes and nicotine pouches, the Journal reported earlier this week, citing people familiar with the matter.Trump's decision is not final and could change, the report said."President Trump has assembled the most experienced and talented administration in history, an administration that continues to focus on delivering more historic victories for the American people," the White House said in an email to.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $68.85, Change: $-0.19, Percent Change: -0.28%

$BTI$MO$PM$RLX$TPB
Wire

Market Chatter: Trump Plans to Fire FDA Commissioner Makary

President Donald Trump has approved a plan to fire Food and Drug Administration Commissioner Marty Makary, the Wall Street Journal reported Friday, citing people familiar with the matter.Trump has expressed his displeasure in recent days with Makary for taking too long to approve flavored vapes and nicotine pouches, the Journal reported earlier this week, citing people familiar with the matter.Trump's decision is not final and could change, the report said.The White House didn't immediately reply to a request for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $69.16, Change: $+0.11, Percent Change: +0.17%

$BTI$MO$PM$RLX$TPB
Wire

Trump Plans to Fire FDA Commissioner Makary, WSJ Reports

Trump Plans to Fire FDA Commissioner Makary, WSJ Reports

$BTI$MO$PM$RLX$TPB
Wire

Market Chatter: Trump Urges FDA Head to Approve Flavored Vapes

President Donald Trump expressed his displeasure with Food and Drug Administration Commissioner Marty Makary for taking too long to approve flavored vapes and nicotine products, The Wall Street Journal reported Tuesday, citing people familiar with the discussions.In a series of calls over the weekend and on Monday, Trump sought advice from advisers, who told him that Makary has blocked the president's vaping agenda, the report said, citing the people.The White House didn't immediately reply to a request for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $83.80, Change: $+2.14, Percent Change: +2.62%

$BTI$MO$RLX$TPB
Wire

Trump Urges FDA Head to Approve Flavored Vapes, The WSJ Reports

Trump Urges FDA Head to Approve Flavored Vapes, The WSJ Reports

$BTI$MO$RLX$TPB
Wire

Altria Shows Solid Profit Momentum Amid Structural Headwinds, Morgan Stanley Says

Altria (MO) showed solid profit momentum and visibility from the double-duty drawback going forward, but structural headwinds persist, Morgan Stanley said in a Friday note.The report said the company reported a "solid" Q1 EPS beat and reiterated its full-year 2026 guidance, adding that it has a balanced risk/reward profile from here."We see limited scope for upward re-rating," the note said, pointing to its recent stock appreciation amid solid financial flexibility from its stake in Anheuser-Busch InBev, $5.6 billion of capital losses, and some 6% dividend yield.Additionally, the report said its limited reduced-risk portfolio is unlikely to move the needle for the company over the mid-term.The report also said Altria has not witnessed an impact on tobacco consumer behavior from higher gasoline prices since the start of the Iran conflict, with consumer spending currently cushioned by higher tax refunds.Morgan Stanley increased its price target to $71 from $62 while retaining its equal-weight rating on the stock.Price: $73.36, Change: $+0.70, Percent Change: +0.97%

$MO
Wire

UBS Adjusts Price Target on Altria to $76 From $74, Maintains Buy Rating

Altria (MO) has an average rating of hold and mean price target of $69.45, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $73.60, Change: $+0.94, Percent Change: +1.30%

$MO
Research

Research Alert: CFRA Maintains Sell Opinion On Shares Of Altria Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Following MO's Q1 earnings release, we raise our estimates and price target but maintain our Sell rating on the stock. We raise our 12-month price target by $10 to $60, based on a 2027 P/E of 10.3x, a slight premium to its five-year mean forward P/E of 10.0x. We are also increasing our adjusted EPS estimates by $0.05 to $5.70 for 2026 and by $0.05 to $5.80 for 2027. MO posted Q1 adjusted EPS of $1.32 vs. $1.23 (+7%). This result was well ahead of the $1.25 consensus. Net revenue rose 5.3% to $4.76B ($180M above consensus) as higher price realizations fully offset lower volumes, which declined 2.3% for smokable products and 3.1% for oral tobacco. While MO maintained 2026 adjusted EPS guidance of $5.56-$5.72, we now see its earnings coming in toward the higher end of the range. Still, MO's earnings release confirmed our concerns regarding market share declines in its on! nicotine pouch product (retail share down 80 bps Y/Y to 7.8% in Q1). Therefore, we continue to view the stock's risk/reward as unfavorable.

$MO
Research

Research Alert: Mo: Q1 Well Ahead Of Expectations; Guidance Unchanged

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Altria (MO) posted Q1 adjusted EPS of $1.32 vs. $1.23 (+7%), well above the $1.25 consensus. Net revenue rose 5.3% to $4.76B ($180M above consensus) as higher price realizations fully offset lower volumes, which declined 2.3% for smokeable products and 3.1% for oral tobacco. MO maintained 2026 adjusted EPS guidance of $5.56-$5.72, the midpoint of which is ahead of the $5.62 consensus and implies Y/Y growth of 2.5%-5.5% from the $5.42 earned in 2025. The company expects more balanced growth between the first and second halves of 2026, with guidance now contemplating moderated e-vapor industry growth impacts and increased macroeconomic uncertainty. MO repurchased $280M in shares and paid $1.8B in dividends during the quarter. Despite the big Q1 beat, MO shares are currently trading flat in pre-market trading, likely reflecting concerns as to why the company didn't raise full-year guidance considering the strength of Q1 results. However, we note that MO has a long history of providing conservative guidance.

$MO
Wire

Altria Q1 Beat Could Drive Fiscal 2026 Estimate Revisions, UBS Says

Altria Group (MO) could deliver a slight Q1 earnings beat that may drive positive revisions to full-year expectations, supported by improving cigarette volume trends and share gains, despite softer price/mix and on! nicotine pouch off-take, UBS Securities said.The brokerage said in a Tuesday research note that improving Smokeable segment volumes are expected to help Altria return to revenue growth, with cigarette shipment declines moderating versus consensus and early signs of volume share gains.The investment firm expects Smokeable operating income to benefit from factors including duty drawback activity, though this is partly offset by mix pressure from the deep discount Basic brand and ongoing investment. UBS also sees price/mix improving from Q2 onward as these headwinds ease.In Smokeless, UBS forecast Q1 sales growth of 2.0%, with 45 million on! cans and OCI declining 1.7%. This implies Q1 Group revenue and OCI growth of 1.6% and 0.6%, respectively, and EPS growth of 2.4% to $1.26.The brokerage expects full-year earnings per share growth of 5.5% to $5.72 and sees potential for acceleration into 2026 and 2027. UBS said it does not expect guidance changes at this stage.Altria is scheduled to report Q1 results on April 30.UBS maintained a buy rating on the company with a $74 price target.Price: $64.85, Change: $+0.20, Percent Change: +0.31%

$MO

Track with the FINWIRES app suite